Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy

    The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held from September 24–27 in Kumamoto, Japan. This prestigious event brought together leading experts from around the world to discuss cutting-edge developments in basic hematology, immunology, stem cell research, and cell and gene therapy. One of the highlights of this…

    2025.09.30
  • CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines

    Q1. Key Conceptual Shifts in Perioperative Therapy Prof. Lili Mao: This year’s CSCO Melanoma Guidelines introduce several important updates regarding perioperative treatment. For cutaneous melanoma, we have added recommendations for…

    2025.09.29
  • Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration

    Key Highlights of the 2025 Conference Prof. Haibo Wang: This year’s conference retained its hallmark sessions, such as expert debates and the signature “Langya Forum,” while introducing several new and…

    2025.09.29
  • “Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer

    From “Blind Box” to “Scientific Fortune-Telling” to “Changing Destiny” At this year’s CSCO breast cancer session, I delivered a talk titled ‘New Perspectives on Neoadjuvant Therapy for Breast Cancer: Those…

    2025.09.29
  • CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology

    Q1. Growth with CSCO and Its Influence Prof. Man Li: I started working in 1996 and became a member of the CSCO family in 1997. My membership number is 19970168—quite…

    2025.09.29
  • Professor Fei Ma: Ushering in a New Era of ‘Chemotherapy + Immunotherapy + Targeted Therapy’ for Advanced Triple-Negative Breast Cancer

    Q1. The Synergy of Chemotherapy, Immunotherapy, and Targeted Therapy Prof. Fei Ma: Triple-negative breast cancer is a subtype of breast cancer, accounting for about 15% of all cases. Among them,…

    2025.09.29
  • ISEH 2025 China–Japan Dialogue | Prof. Jianxiang Wang and Prof. Naoki Hosen: Direct Insights into CAR-T Therapy for Leukemia and a New Blueprint for International Collaboration 

    The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held in Kumamoto, Japan, from September 24–27. The conference brought together leading experts in hematology from around the world to discuss cutting-edge progress in basic hematology, immunology, stem cell research, and cell and gene therapies. During the meeting, Oncology Frontier…

    2025.09.29
  • Breaking New Ground in Systemic Therapy for Kidney Cancer

    2025.09.28
next»
Recent Posts
  • ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy
  • CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines
  • Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration
  • “Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer
  • CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top